Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Immunotherapy with LAK Cells and Anti-CD20 Monoclonal Antibodies for Follicular Lymphoma: Enhanced Antibody-Dependent Cell Cytotoxicity of LAK Cells in Association with GA101 Rather Than Rituximab

Carlos Panizo, Susana Inoges, MD, PhD, Ascensión López Díaz de Cerio, Ph D, Ricardo García Muñoz, MD, Fernando Pastor, PhD, Carlos Grande García, MD, Mayte Olave, MD, PhD, Luis Palomera, MD, Jose J. Rifon, MD, Sara Barea, MD, Ana Alfonso, MD, Maurizio Bendandi, MD, PhD

Blood (2012) 120 (21): 4881.

https://doi.org/10.1182/blood.V120.21.4881.4881

Published: 2012

Journal Articles

Patients’ Peripheral Blood as a Possible Source of Donor-Derived NK Cells for Ex Vivo Expansion and Genetic Modification for Post-Transplant Cellular Immunotherapy In Cord Blood Recipients

Chihaya Imai, MD, PhD, Sakiko Yoshida, MD, PhD, Takayuki Takachi, MD, Masaru Imamura, MD, PhD, Ryosuke Hosokai, MD, Haruko Iwabuchi, MD, PhD, Makoto Uchiyama, MD, Keiko Asami, MD, Atsushi Ogawa, MD, Akihiro Watanabe, MD

Blood (2010) 116 (21): 2094.

https://doi.org/10.1182/blood.V116.21.2094.2094

Published: 2010

Journal Articles

N-Acetylcysteine Mildly Inhibits the Graft vs Leukemia Effect but Not the Lymphokine Activated Cells (LAK) Activity.

Michael Y. Shapira, MD, Lola Weiss, PhD, Shoshana Reich, Michael Zeira, PhD, Shimon Slavin, MD

Blood (2006) 108 (11): 5171.

https://doi.org/10.1182/blood.V108.11.5171.5171

Published: 2006

Journal Articles

Tumor-Activated Human NK Cells Specificall Ylyse Autologous and Allogeneic NK-Resistant Tumor Targets.

Mark W. Lowdell, PhD, Ismail Bakhsh, MSc, Janet North, MSc, Chloe Marden, PhD, Elena Addison, MSc, Stephen Mackinnon, MD

Blood (2006) 108 (11): 3707.

https://doi.org/10.1182/blood.V108.11.3707.3707

Published: 2006

Journal Articles

Adoptive Immunotherapy Using Zoledronate-Activated gd T LAK Cells to Patients with Multiple Myeloma: A Pilot Study.

Kenshi Suzuki, Andrew Nicol, Isao Matuda, Yuki Mori, Yasunori Nakagawa

Blood (2006) 108 (11): 5096.

https://doi.org/10.1182/blood.V108.11.5096.5096

Published: 2006

Journal Articles

Enhancement of Lymphokine-Activated Killer Cell Cytotoxicity by Mistletoe Plant Extracts.

Georg Seifert, Holger N. Lode, MD, Stephan Lobitz, MD, Karl Seeger, MD, PhD, Alfred Laengler, MD, Guenter Henze, MD

Blood (2005) 106 (11): 3919.

https://doi.org/10.1182/blood.V106.11.3919.3919

Published: 2005

Journal Articles

Bcl-x Is Indispensable for the Development of Natural Killer Cells.

Jason G. Harb, PhD, Malarkannan Subramaniam, PhD, Claudia S. Huettner, PhD

Blood (2005) 106 (11): 340.

https://doi.org/10.1182/blood.V106.11.340.340

Published: 2005

Journal Articles

Orphan Granzymes Downstream from Granzyme B Are Important for Tumor Clearance In Vivo and in Vitro .

Xuefang Cao, PhD, Paula A. Revell, PhD, William J. Grossman, MD, PhD, Dori A. Thomas, PhD, Zhi Hong Lu, PhD, Timothy J. Ley, MD

Blood (2004) 104 (11): 2653.

https://doi.org/10.1182/blood.V104.11.2653.2653

Published: 2004

Journal Articles

Endothelial Cell Injury of Carmustine (BCNU) in Hepatic Sinusoids: Contribution of Oxidation and Immune Reaction.

Oner Ozdemir, MD, Yaddanapudi Ravindranath, MD, Sureyya Savasan, MD

Blood (2004) 104 (11): 1154.

https://doi.org/10.1182/blood.V104.11.1154.1154

Published: 2004

Journal Articles

Aerolysin Cytotoxicity Can Serve as a Surrogate Marker for Immune Sensitivity of Tumor Cells to Granule-Exocytosis Pathway in Vitro.

Oner Ozdemir, MD, Mustafa Buyukavci, MD, Yaddanapudi Ravindranath, MD, Sureyya Savasan, MD

Blood (2004) 104 (11): 3864.

https://doi.org/10.1182/blood.V104.11.3864.3864

Published: 2004

Journal Articles

Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients

Dominique Valteau-Couanet, Christophe Leboulaire, Kim Maincent, Muriel Tournier, Olivier Hartmann, Jean Bénard, Françoise Beaujean, Catherine Boccaccio, Laurence Zitvogel, Eric Angevin

Blood (2002) 100 (7): 2554–2561.

https://doi.org/10.1182/blood.V100.7.2554

Published: 2002

Journal Articles

The 5′ Flanking Region of the Human Granzyme H Gene Directs Expression to T/Natural Killer Cell Progenitors and Lymphokine-Activated Killer Cells in Transgenic Mice

Debra M. MacIvor, Christine T.N. Pham, Timothy J. Ley

Blood (1999) 93 (3): 963–973.

https://doi.org/10.1182/blood.V93.3.963

Published: 1999

Journal Articles

Role of Spontaneous and Interleukin-2–Induced Natural Killer Cell Activity in the Cytotoxicity and Rejection of Fas + and Fas − Tumor Cells

Mike Bradley, Ahmet Zeytun, Asimah Rafi-Janajreh, Prakash S. Nagarkatti, Mitzi Nagarkatti

Blood (1998) 92 (11): 4248–4255.

https://doi.org/10.1182/blood.V92.11.4248

Published: 1998

Journal Articles

Natural Killer and B-Lymphoid Potential in CD34 + Cells Derived From Embryonic Stem Cells Differentiated in the Presence of Vascular Endothelial Growth Factor

Naoki Nakayama, Inghwa Fang, Gary Elliott

Blood (1998) 91 (7): 2283–2295.

https://doi.org/10.1182/blood.V91.7.2283

Published: 1998

Journal Articles

Interleukin-12–Activated Natural Killer Cells Recognize B7 Costimulatory Molecules on Tumor Cells and Autologous Dendritic Cells

Anja B. Geldhof, Muriel Moser, Laurence Lespagnard, Kris Thielemans, Patrick De Baetselier

Blood (1998) 91 (1): 196–206.

https://doi.org/10.1182/blood.V91.1.196

Published: 1998

Journal Articles

Differential Cytotoxicity of Cord Blood and Bone Marrow–Derived Natural Killer Cells

Clair M. Gardiner, Anne O' Meara, Denis J. Reen

Blood (1998) 91 (1): 207–213.

https://doi.org/10.1182/blood.V91.1.207

Published: 1998

NARROW

Immunotherapy with LAK Cells and Anti-CD20 Monoclonal Antibodies for Follicular Lymphoma: Enhanced Antibody-Dependent Cell Cytotoxicity of LAK Cells in Association with GA101 Rather Than Rituximab

Patients’ Peripheral Blood as a Possible Source of Donor-Derived NK Cells for Ex Vivo Expansion and Genetic Modification for Post-Transplant Cellular Immunotherapy In Cord Blood Recipients

N-Acetylcysteine Mildly Inhibits the Graft vs Leukemia Effect but Not the Lymphokine Activated Cells (LAK) Activity.

Tumor-Activated Human NK Cells Specificall Ylyse Autologous and Allogeneic NK-Resistant Tumor Targets.

Adoptive Immunotherapy Using Zoledronate-Activated gd T LAK Cells to Patients with Multiple Myeloma: A Pilot Study.

Enhancement of Lymphokine-Activated Killer Cell Cytotoxicity by Mistletoe Plant Extracts.

Bcl-x Is Indispensable for the Development of Natural Killer Cells.

Orphan Granzymes Downstream from Granzyme B Are Important for Tumor Clearance In Vivo and in Vitro .

Endothelial Cell Injury of Carmustine (BCNU) in Hepatic Sinusoids: Contribution of Oxidation and Immune Reaction.

Aerolysin Cytotoxicity Can Serve as a Surrogate Marker for Immune Sensitivity of Tumor Cells to Granule-Exocytosis Pathway in Vitro.

Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients

The 5′ Flanking Region of the Human Granzyme H Gene Directs Expression to T/Natural Killer Cell Progenitors and Lymphokine-Activated Killer Cells in Transgenic Mice

Role of Spontaneous and Interleukin-2–Induced Natural Killer Cell Activity in the Cytotoxicity and Rejection of Fas + and Fas − Tumor Cells

Natural Killer and B-Lymphoid Potential in CD34 + Cells Derived From Embryonic Stem Cells Differentiated in the Presence of Vascular Endothelial Growth Factor

Interleukin-12–Activated Natural Killer Cells Recognize B7 Costimulatory Molecules on Tumor Cells and Autologous Dendritic Cells

Differential Cytotoxicity of Cord Blood and Bone Marrow–Derived Natural Killer Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only